25 Jul, EOD - Indian

SENSEX 80039.8 (-0.14)

Nifty 50 24406.1 (-0.03)

Nifty Bank 50888.75 (-0.83)

Nifty IT 40055.45 (-0.15)

Nifty Midcap 100 56741.75 (-0.23)

Nifty Next 50 72210.25 (0.51)

Nifty Pharma 21105.5 (0.94)

Nifty Smallcap 100 18673.05 (-0.27)

25 Jul, EOD - Global

NIKKEI 225 37869.51 (-3.28)

HANG SENG 17004.97 (-1.77)

DOW JONES 39853.87 (-1.25)

S&P 5427.13 (-2.31)

Login/Signup

Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(24 Jul 2024, 10:27)

Torrent Pharma Q1 PAT climbs 21% YoY to Rs 457 crore

Torrent Pharmaceuticals reported that its consolidated net profit increased 20.9% to Rs 457 crore in Q1 FY25 as compared with Rs 378 crore recorded in Q1 FY24.

Revenue from operations rose 10.34% year on year (YoY) to Rs 2,859 crore in the quarter ended 30 June 2024.

Profit before tax stood at Rs 656 crore in June 2024 quarter, up 23.54% from Rs 433 crore posted in same quarter last year.

Operating EBITDA stood at Rs 904 crore in Q1 FY25, registering a growth of 14% as against Rs 791 crore reported in Q1 FY24.

The company's India revenue grew by 15% YoY to Rs 1,635 crore in Q1 FY25, led by outperformance in focus therapies. As per All India Organization of Chemists & Druggists (AIOCD) secondary market data, IPM growth for the quarter was 8%. Torrent’s chronic business grew at 14% versus IPM growth of 8%, driven by strong revival in cardiac divisions and continued traction in anti-diabetes (OAD) new launches.

Torrent Pharma's Bra...

More News
More Company News View Company Information